Sort
50,496 grants matching “lung cancer”
Precision magnetic hyperthermia by integrating magnetic particle imaging
$677,029Robert Ivkov · Johns Hopkins University · R01 · FY2021 · CA
Intervention of Pancreatic Oncogenic Pathways with Dietary Tocotrienol
$677,025Mokenge P. Malafa · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2009 · CA
Improving Cancer Outcomes for African-Americans
$677,000Patrick D Maguire · New Hanover Regional Medical Center · U56 · FY2007 · CA
Regulation Of Immune Responses In Humans and in Experimental Animals
$676,945Warren Strober · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Prostate Cancer Studies
$676,908Michael Cook · Division Of Cancer Epidemiology And Genetics · ZIA · FY2016 · CA
Promoting Equity of Cancer Screening and Follow-up for Lung Cancer.
$676,845Chyke Abadama Doubeni · Ohio State University · R01 · FY2025 · CA
Social media support groups for adolescent vaping cessation
$676,818Pamela May Ling · University Of California, San Francisco · R01 · FY2025 · CA
Tumor Microenvironment in Cancer Progression
$676,757Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Intensive tailored exercise training with NAD+ precursor supplementation to improve muscle mass and fitness in adolescent and young adult survivors of hematopoietic stem cell transplantation
$676,745Sogol Mostoufi-Moab · Children'S Hosp Of Philadelphia · R01 · FY2023 · CA
Chemoprevention of Prostate Cancer, HDAC Inhibition, and DNA Methylation
$676,744Emily Ho · Oregon State University · P01 · FY2010 · CA
Discovery and characterization of clinically actionable germline mutations in DNA damage repair (DDR) pathway genes in lung cancer
$676,729Semanti Mukherjee · Sloan-Kettering Inst Can Research · R37 · FY2024 · CA
Mitochondrial dysfunction in pulmonary hypertension
$676,676Olga Rafikova · Indiana University Indianapolis · R01 · FY2025 · HL
Infections, immunity, and inflammation in cancer
$676,674Eric A Engels · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA
Shanghai Men's Health Study
$676,671Xiao-Ou Shu · Vanderbilt University Medical Center · UM1 · FY2015 · CA
A Registry-Based Study of Patterns of Use of Targeted Therapies for Metastatic Cancers in Diverse Populations
$676,657Christine Veenstra · University Of Michigan At Ann Arbor · R37 · FY2021 · CA
CHARGE consortium: gene discovery for CVD and aging phenotypes
$676,646Bruce M Psaty · University Of Washington · R01 · FY2020 · HL
Decoding the co-evolution of cancer subclones and their ecosystem in TNBC multi-organ metastasis
$676,584Nicholas Navin · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Systematic Testing of a TGFβ Targeted Theranostic in Preclinical Cancer
$676,567Mary Helen Barcellos-Hoff · University Of California, San Francisco · R01 · FY2025 · CA
Integrated blood and radiomic subtyping to guide immunotherapy treatment selection and early response assessment in metastatic non-small cell lung cancer
$676,561Natalie Vokes · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Molecular and Imaging Biomarkers for Early Lung Cancer Detection in the Setting of Indeterminate Pulmonary Nodules
$676,510Avrum E Spira · Boston University Medical Campus · R01 · FY2016 · CA
Overcoming adaptive feedback resistance to KRAS inhibition in colorectal cancer
$676,391Ryan Bruce Corcoran · Massachusetts General Hospital · R01 · FY2024 · CA
Leadership, Planning, and Evaluation
$676,378Stanton L Gerson · Case Western Reserve University · P30 · FY2019 · CA
Improving risk stratification for lung cancer screening using peripheral blood leukocyte DNA methylation: an investigation in the National Lung Screening Trial (NLST)
$676,338Dominique S Michaud · Tufts University Boston · R01 · FY2025 · CA
Molecular Mechanisms Regulating Endothelial Dysfunction
$676,330Hong Chen · Boston Children'S Hospital · R01 · FY2019 · HL
Molecular Mechanisms Regulating Endothelial Dysfunction
$676,330Hong Chen · Boston Children'S Hospital · R01 · FY2020 · HL